Bionow | News

Lancaster University joins forces with British biomedical firm ViraCorp to creat...

Dec 16th 2021

A new partnership between Lancaster University and biomedical firm ViraCorp has been launched to develop a unique nasal COVID-19 vaccine which attacks the virus at its entry point into the b...

Liability on the frontline - Five-part report series

Aug 13th 2021

From fast-tracked clinical trials to emergency medical devices and telehealth innovations, the Life Sciences sector is providing solutions to Covid-19. This series of reports explores what r...

Preventing transmission of coronavirus with surfaces and coatings technology

Apr 27th 2021

SARS-CoV-2 was first identified over a year ago. With multiple lockdowns, restrictions, and finally a vaccine on the way, it’s been a long journey in slowing transmission of the virus. Adv...

World's first COVID-19 vaccine alternating dose study launches in Liverpool

Feb 4th 2021

Study will examine using different vaccines for the two doses, as well as different intervals between doses

Liability on the Frontline - Part 4: Fighting COVID-19 with genomics

Jan 14th 2021

Genomics has provided us with a new armoury for tackling pandemics, enabling us to respond faster and with more accuracy to COVID-19.

Liability on the Frontline - Part 3: The great telehealth experiment

Nov 30th 2020

The pandemic has fast-tracked telehealth into the mainstream, so what are the risks that technology companies should be aware of as they expand and innovate quickly?

AI-based drug discovery tool free access extended

Nov 8th 2020

As the world enters a new wave of lockdowns, Biorelate, a Manchester-based AI start up, extends its free use of Galactic to all researchers.

Liability on the Frontline - Part 2: Making medical devices during a pandemic

Oct 15th 2020

How has the coronavirus pandemic affected the risk profile of medical device manufacturing?

Liability on the Frontline - Part 1: Emerging risks in Covid-19 clinical trials

Oct 14th 2020

With the scientific community throwing everything it has at Covid-19, best practice is slipping in clinical trials. What trade-offs are being made and who is liable?

LSTM researchers find an easy alternative to nasal and throat swabbing for SARS-...

Sep 17th 2020

Researchers have found that saliva samples are just as effective at diagnosing COVID-19 as respiratory swabs that are currently being used.

Cobra Biologics signs supply agreement with AstraZeneca for manufacture of COVID...

Jun 17th 2020

Providing large scale manufacturing capacity for AZD1222

Yourgene COVID-19 testing service launch and business update

May 28th 2020

Manchester, UK – 26 May 2020: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces it has expanded its laboratory capabilities to offer COVID-19 testing ser...

News